ArticleDoklady. Biochemistry and biophysics2025
Avicularin as a Promising Therapeutic Agent for Gestational Diabetes Mellitus: Modulation of Inflammatory, Oxidative Stress, and Apoptotic Pathways.
Article in Doklady. Biochemistry and biophysics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Spatiotemporal heterogeneity of neutrophil extracellular traps in hepatocellular carcinoma microenvironment and targeted therapy progress.Journal of translational medicine · 2026Review
- Protective effect of tectorigenin against streptozotocin-induced gestational diabetes mellitus in rats via alteration of inflammation, oxidative stress, HO-1/Nrf2 and NF-κB/COX-2/iNOS signaling pathway.Naunyn-Schmiedeberg's archives of pharmacology · 2026Article
- Microarray Analysis of Differentially Expressed Genes in Peripheral Blood of Postpartum Women with Gestational Diabetes Mellitus and Type 2 Diabetes.Life (Basel, Switzerland) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
ackgroundGestational diabetes mellitus (GDM) is a significant pregnancy complication characterized by elevated blood glucose levels. This condition arises from insulin resistance and impaired glucose metabolism during the gestational period. In this experimental study, we investigated the protective effect of avicularin against streptozotocin (STZ)-induced GDM in rats and explored the underlying mechanism. MATERIAL AND
methodsFemale Swiss Wistar rats were utilized in this study. Gestational diabetes mellitus (GDM) was induced in the rats through the administration of 25 mg/kg streptozotocin (STZ). The rats received oral administration of avicularin at doses of 5, 10, and 15 mg/kg. Body, placental, and fetal weights were measured. Blood glucose levels (BGL) and plasma insulin were assessed at various time intervals. Levels of glycogen, glycated hemoglobin (HbA1c), hemoglobin (Hb), visfatin, intercellular adhesion molecule-1 (ICAM-1), vascular cell adhesion molecule-1 (VCAM-1), antioxidants, lipids, inflammatory cytokines, apoptotic markers, and inflammatory parameters were evaluated. Additionally, mRNA expression was analyzed in hepatic tissue.
resultsAvicularin significantly (p < 0.001) improved the body weight, fetal body weight and reduced the placental weight. Avicularin significantly (p < 0.001) suppressed the elevated blood glucose level and improved the plasma insulin level. Avicularin significantly (p < 0.001) altered the levels of HbA1c, Hb, visfatin, ICAM-1, VCAM-1, LPO, CAT, GSH, GPx, SOD, GST, TNF-α, IL-1β, IL-6, Il-8, IL-10, IL-18, COX-2, PGE2, iNOS, NF-κB, Bax, Bcl-2, Bcl-2:Bax ratio and caspase-3 parameters. Avicularin treatment significantly (p < 0.001) suppressed the mRNA expression of TRL4, MyD88, NF-κB, NLRP3, RAGE, VCAM-1, MCP-1, VEGF, Nox2, and p65.
conclusionThe results of this study demonstrated the protective effect of avicularin against streptozotocin-induced gestational diabetes mellitus via modulation of the TLR4/MyD88/NF-κB and Bax/Bcl-2/Caspase pathways.
Indexed as
Identifiers
40216713What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.